US9969754 — Compounds for treating spinal muscular atrophy
Method of Use · Assigned to Hoffmann La Roche Inc · Expires 2035-05-11 · 9y remaining
What this patent protects
This patent protects compounds of formula (I) and their use as medicaments, as well as their manufacture and pharmaceutical compositions.
USPTO Abstract
The present invention provides compounds of formula (I) wherein A, R 1 , R 2 and R 3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.
Drugs covered by this patent
- Evrysdi (RISDIPLAM) · Roche
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1943 |
— | Evrysdi |
U-1943 |
— | Evrysdi |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.